SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
SARS-CoV-2 AND THE HOST IMMUNE RESPONSE: GOOD VS BAD IMMUNITY
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
SESSION OVERVIEW
Nicolas Chomont
Université de Montréal, Montreal, Canada
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
SARS-COV-2 DEBRIS AND ITS CONTRIBUTION TO COVID-19
Benjamin tenOever
Icahn School of Medicine at Mount Sinai, New York, NY, USA
TOWARD SWEET THERAPIES FOR SOUR IMMUNOPATHOLOGIES IN COVID-19
Catherine A Blish
Leland Stanford Junior University, Stanford, CA, USA
AFUCOSYLATED IGG RESPONSES AND SEVERITY IN COVID-19
Gestur Vidarsson
Sanquin Research/University of Amsterdam, Amsterdam, Netherlands
ANTICIPATING ESCAPE PATHWAYS FOR SARS-COV-2
Julie Overbaugh
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
THE SPECTRUM OF T CELL RESPONSES TO SARS-COV-2
Marcus Buggert
Karolinska Institutet, Huddinge, Sweden
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
